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Introduction. The cardiovascular impact of a patent arteriovenous 
fistula (AVF) following kidney transplantation has not been clearly 
described. This study aimed to evaluate the natural history of AVFs 
in kidney transplant recipients and the effect of spontaneous AVF 
closure after kidney transplantation on cardiac status. 
Materials and methods. Data on vascular access for dialysis were 
collected from medical charts of kidney transplant recipients between 
July 2009 and November 2010 at a single center. Echocardiographic 
re-assessment of the AVF flow and cardiac status was done in 
selected patients with functioning and nonfunctioning AVFs.
Results. Of 180 kidney transplant recipients, 142 had AVFs before 
transplantation and 99 (69.7%) had a functioning fistula at the time 
of study after kidney transplantation. Twenty-three patients with 
a functioning AVF were compared with 17 with spontaneously 
closed AVFs. The left ventricular ejection fraction improved in 
both groups posttransplant. In the group with patent fistulas, 
there was a trend towards lower value of left ventricular end-
systolic and end-diastolic diameters, but it did not reach statistical 
significance. The mean fistula flow was 560 ± 405 mL/min in this 
group. A significant reduction was observed in the interventricular 
septum and left ventricular posterior wall diameters in the group 
with closed AVFs. 
Conclusions. Spontaneous AVF closure did not offer a significant 
cardiac beneficial effect. There are insufficient data to promote 
systematic closure of AVF after successful kidney transplantation.
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INTRODUCTION
One of the common treatment options of 
patients suffering from end-stage renal disease is 
hemodialysis. Hemodialysis is usually done through 
a vascular access route, ie, arteriovenous fistula 
(AVF). Arteriovenous fistula is a nonphysiologic 
vascular access which is imposed on cardiovascular 
system1; however, it is the best vascular access for 
hemodialysis and has lower risk of side effects, 
especially infection, in comparison with other 
vascular access methods.2 
Arteriovenous fistula decreases systemic vascular 
resistance, causing increased stroke volume and 
cardiac output in order to maintain blood pressure, 
and this can cause left ventricular volume overload 
and eccentric left ventricular hypertrophy.3 Although 
the chronic volume overload caused by AVF induces 
structural and functional changes on cardiovascular 
system, whether these changes increase mortality and 
morbidity in patients is unclear.4 Some researchers 
believe that AVF has destructive effects on the 
cardiovascular system, such as left ventricular 
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hypertrophy,3,5-7 high-output cardiac failure,3,8,9 
and other symptoms of cardiovascular diseases, 
such as hypertension and aortic stiffness.1,10 Some 
others believe that AVF has negligible effects on 
cardiovascular system in long term.6,11 Although 
there is agreement that AVF makes considerable 
structural changes in the cardiovascular system 
in long term, there is no consensus on functional 
changes at least in an AVF with normal-range flow.1 
Successful kidney transplantation improves 
uremia, normalizes hemoglobin level, increases 
serum albumin, and improves left ventricular volume 
and volume status. These factors theoretically reduce 
left ventricular hypertrophy,4,12,13 although some 
factors such as uncontrolled hypertension and 
anemia my interfere in creation and continuation 
of left ventricular hypertrophy.4 Some studies have 
shown that left ventricular dimension is improved 
after kidney transplantation, but left ventricular 
hypertrophy does not completely reverse.3,11,14 
Arteriovenous fistulas may be another factor that 
impede improvement of left ventricular hypertrophy. 
They usually remain unused and are usually 
forgotten after successful kidney transplantation. 
Some of these fistulas are closed spontaneously.2 
Given the need for vascular access on one hand 
and the negative effects of AVF on cardiac function 
and morphology on the other hand, the value of 
keeping an AVF patent or deciding to close it is 
a challenging decision after a successful kidney 
transplantation.4 Although closure of the AVF may 
be useful for the patient, it destroys a valuable 
vascular access, which is necessary for returning 
the patient to dialysis in case of graft loss.5 
No distinctive criteria have been proposed to 
decide how to manage a functioning AVF after 
successful kidney transplantation.1,2,4 Few studies 
of the natural history of these fistulas have been 
published. More information is necessary to specify 
which patient benefits from closure of the AVF. 
The aim of this study was to evaluate the outcome 
of preserving AVF after kidney transplantation 
and to compare echocardiographic parameters 
before and after transplantation in patients with 
functioning AVF with those who have closed AVF. 
MATERIALS AND METHODS 
Patients
This study included all patients who had kidney 
transplantation from July 2009 to November 2010 
at Hasheminejad Kidney Center. Data on the 
patients including demographic specifications, 
associated disorders, dialysis modality before 
kidney transplantation, allograft function, and 
AVF outcome were collected and analyzed. In a 
second phase of the study, transplant recipients 
who met the following criteria were enrolled: 
successful kidney transplantation, having a 
functioning AVF before transplantation, having 
undergone complete standard echocardiographic 
study before transplantation, and absence of major 
cardiac disorders on cardiac assessments before 
transplantation. This cohort was divided into 2 
groups of those with functioning and nonfunctioning 
AVF. Fistula flow in the functioning AVF group 
was measured and then echocardiography was 
performed in both groups, 6 to 18 months after 
transplantation, and cardiac parameters were 
assessed for comparison with pretransplant 
echocardiography results. 
Fistula Flow
Fistula flow was assessed using the Siemens-
Acuson X500 ultrasonography device (Siemens, 
Erlangen, Germany) with a linear multifrequency 
probe operating at 5 MHz to 10 MHz. Arterial flow 
was measured immediately proximal and distal 
to the fistula and the flow was calculated. Flow 
volume obtained using the algorithm available 
on the system in the D-Flow method based on 
the mean flow.
Echocardiography 
Two-dimensional  echocardiography was 
performed using the Vivid S5 (GE Healthcare, 
New York, USA). The following parameters were 
assessed: ejection fraction, left ventricular end-
diastolic diameter, left ventricular end-systolic 
diameter, interventricular septum diameter, 
posterior wall diameter, and left atrial diameter.
Statistical Analyses
Data analysis was done using the SPSS software 
(Statistical Package for the Social Sciences, version 
18.0, SPSS Inc, Chicago, Ill, USA). Continous 
variables were described as mean ± standard 
deviation. Changes in echocardiographic parameters 
before and after transplantation were analyzed 
by the paired t test. A P value less than .05 was 
considered significant.
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RESULTS 
From July 2009 to November 2010, a total of 212 
patients undewent kidney transplantation at our 
center. Clinical records of 180 patients were available 
for this study (117 men and 63 women with a mean 
age of 41.7 ± 13.2 years). The mean follow-up time 
from kidney transplantation was 13.9 ± 4.8 months, 
and the mean duration of hemodialysis before 
kidney transplantation was 29.6 ± 17.3 months. 
Sixteen of the 180 patients (8.9%) had preemptive 
kidney transplantation, and 6 patients (3.3%) had 
been on peritoneal dialysis before transplantation. 
Of the remaining 158 patients (86.8%) who had 
been on hemodialysis, 142 (78.9%) had an AVF 
and 16 (8.9%) had a catheter or artificial vessel 
for vascular access. 
Five patients died during the follow-up period 
and 6 patients lost their graft function and strarted 
on dialysis again, all through their previous 
AVF. Among the patients who had functioning 
AVFs before transplantation, 99 (69.7%) had 
a functioning fistula at the time of study after 
kidney transplantation. In 34 patients, the fistula 
was spontaneosly closed and 4 patients had their 
fistula surgically closed. 
There were 40 patients with successful kidney 
transplantation who had been on hemodialysis 
through AVF and had undergone complete 
standard echocardiographic study before kidney 
transplantation with the results indicative of no 
major cardiac disorder. They were divided into 
2 groups with functioning and nonfunctioning 
AVFs. Clinical characteristics of these two groups 
are summarized in Table 1. Echocardiography 
parameters in both groups were similar before 
kidney transplantation. Echocardiographic re-
assessment after kidney transplantation showed 
improvement in the ejection fraction in both 
groups with functioning and nonfunctioning AVFs 
(Table 2). Reduction in the interventricular septum 
and posterior wall diameters in the group with 
nonfunctioning AVFs was significant, while in the 
group with functioning AVFs, only changes in the 
interventricular septum diameter were statistically 
arginally significant (P = .06). There was also 
a significant increase in the left atrial diameter 
posttransplantation in the patent AVF group. 
DISCUSSION
The strategy for AVF management after successful 
kidney transplantation is debatable. Keeping the 
AVF may be useful in case the transplanted kidney 
fails and the patients requires dialysis. On the other 
hand, a functioning AVF remained unused after 
Parameter
Patients with active AVF Patients with inactive AVF
Before Transplantation After Transplantation P Before Transplantation After Transplantation P
EF, % 52.82 ± 3.90 54.34 ± 2.30 .02 52.05 ± 3.10 54.11 ± 2.00 .03
LVEDD, cm 4.84 ± 0.48 4.74 ± 0.46 > .05 4.87 ± 0.38 4.85 ± 0.47 > .05
LVESD, cm 3.15 ± 0.54 3.12 ± 0.61 > .05 3.39 ± 0.47 3.42 ± 0.58 > .05
IVSD, cm 1.22 ± 0.18 1.24 ± 0.19 .06 1.16 ± 0.11 1.10 ± 0.11 .002
PWD, cm 1.23 ± 0.19 1.24 ± 0.19 > .05 1.17 ± 0.11 1.10 ± 0.11 .001
LAD, cm 3.50 ± 0.38 3.70 ± 0.44 .006 3.48 ± 0.55 3.50 ± 0.58 > .05
*EF indicates ejection fraction; LVED, left ventricular end-diastolic diameter; LVESD, left ventricular end-systolic diameter; IVSD, interventricular 
septum diameter; PWD, posterior wall diameter; and LAD, left atrial diameter.
Table 2. Echocardiographic Parameters Before and After Kidney Transplantation*
Characteristic
Kidney Transplant Recipients
P
Functioning AVF Nonfunctioning AVF
Number 23 17
Age, y 49.1 ± 11.8 39.2 ± 12.4 .05
Gender 
Male 16 12
Female 7 5 .94
Reassesment Time after transplantation, mo 11.1 ± 3.5 (6 to 18) 12.0 ± 3.5 (7 to 17) .43
Time between fistula creation and transplantation, mo 29.9 ± 15.8 (10 to 71) 31.9 ± 16.7 (10 to 72) .70
AVF flow, mL/min 560.9 ± 405.8 (105 to 1591) … …
*AVF indicates arteriovenous fistula.
Table 1. Clinical Characteristics*
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kidney transplantation may lead to complications 
of the fistula itself or cardiovascular disorders. 
Complications of AVF are not rare and include 
steal syndrome, arm edema, thrombosis, and rarely, 
traumatic bleeding. Moreover, the presence of a 
dilatated and pulsatile fistula is a cosmetic issue 
for some patients.4 
Some fistulas close spontaneously after kidney 
transplantation. Manca and colleagues showed in a 
retrospective study on 365 patients with successful 
kidney transplantation that AVF was spontaneously 
closed in 125 patients (34%).2 In our study, 34 out 
of 142 patients experienced spontaneous closure 
of AVF after kidney transplantation (24%). This 
relatively lower rate can be due to shorter follow-
up time in our study. 
The effect  of  an active AVF after kidney 
transplantation on cardiovascular parameters 
remains a matter of debate. In our study, it was 
shown that in comparison with the results of 
echocardiography before kidney transplantation, 
ejection fraction in both groups with functioning 
and nonfunctioning AVF had improvement due to 
correction of uremia, normalization of hemoglobin 
level, and improved volume status after successful 
kidney transplantation. In this study, some decreases 
in dimensions and volume of the left ventricle 
occurred in both groups. Although these changes 
were more evident in the group with functioning 
AVF, the difference was not statistically significant. 
In the nonfunctioning AVF group, changes in 
the posterior wall diameter of the left ventricle 
and interventricular septum diameter were more 
prominent. Peteiro and coworkers, in a prospective 
study on 30 patients after kidney transplantation, 
showed that left ventricular mass index and left 
ventricular end-diastolic volume were reduced. 
However, this reduction was not different between 
the two groups with functioning and closed AVF 
and depended more on blood pressure control.11 
De Lima and coleagues retrospectively studied 
on 61 patients receiving kidney transplantation 
(39 patients with functioning AVF and 22 with 
closed AVF) and found that there was no difference 
between the two groups in the left ventricular 
mass, cardiac index, ejection fraction, and left 
ventricular hypertrophy.6 Van Duijnhoven and 
coworkers studied the effect of closing AVF after 
successful kidney transplantation on 20 patients 
in a prospective study. They found a reduction 
in end-diastolic diameter (51.5 ± 5.8 mm versus 
49.3 ± 5.4, P < .01) and left ventricular mass index 
(135.0 ± 34.1 mm versus 119.8 ± 23.2, P < .01).3 Unger 
and colleagues found in a case-control prospective 
study on 17 patients that surgical AVF closure 
reduced left ventricular mass index from 139 ± 44 
g/m2 to 127 ± 45 g/m2 (P = .001).15 
Sheashaa and colleagues compared 17 patients 
receiving kidney transplantation whose AVF closed 
spontaneously within 1 month after transplantation 
with a control group including 34 patients with 
functioning AVF. Although the end-systolic 
and end-diastolic volumes and diameters of the 
left ventricle were lower in the first group, this 
difference was not significant; however, cardiac 
index and cardiac output were higher in the first 
group.16 Cridlig and coworkers studied on 76 
patients receiving successful kidney transplantation 
(38 patients with functioning AVF and 38 patients 
with nonfunctioning AVF) and showed that a patent 
AVF in these patients caused a more prominent 
increase in the left ventricular mass index relative 
to patients with nonfunctioning AVF (112.4 ± 28.0 
g/m2 versus 135.1 ± 30.3 g/m2, P < .001).17 Valek 
and colleagues studied on 15 patients with AVF 
flows above 1300 mL/min and 40 patients with 
fistula flows of 200 mL/min to 1400 mL/min. 
They found that AVFs with normal flow had less 
effect on cardiovascular parameters, but higher 
flows, especially above 1400 mL/min, caused an 
increasein the left ventricular load and could be 
accompanied by high-output cardiac failure.1 
The fact that functioning AVF after kidney 
t r a n s p l a n t a t i o n  c a u s e s  d e t e r i o r a t i o n  o f 
cardiovascular system and increase of morbidity 
and mortality is doubtful. The published studies do 
not support clearly beneficial effects of closing AVF 
on cardiovascular parameters at least in normal-
range fistula flow and patients lacking other risk 
factors such as uncontrolled hypertension. Thus, 
more large-scale studies are necessary to clarify 
this issue. At present, we do not recommend 
routine closure of AVFs after successful kidney 
transplantation. However, it could be an option 
in case of stable graft function and absence of 
any rejection episode, especially in patients with 
cardiac disorders. Obviously, we should consider 
the peripheral vascular status as an influential 
factor on making the decision. 
The major  l imitat ion of  our  s tudy is  i ts 
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retrospective nature and the short follow-up time. 
It is difficult to design any prospective study to 
show the effect of spontaneous obliteration of AVFs. 
CONCLUSIONS
Morbidity and mortality of cardiac disease in 
patients receiving kidney transplantation are higher 
than those of the general population. Surgical 
or spontaneous closure of AVF after successful 
kidney transplantation can improve some cardiac 
parameters, but the assumption that this leads to 
reduction of cardiac morbidity and mortality has 
not been proven and prospective and randomized 
studies are required to prove it. At present, we may 
not recommend routine closure of AVF after kidney 
transplantation, but we believe in considering graft 
function, age, and cardiovascular status of the 
patients, as well as ease and feasibility of creating 
a new AVF if needed, when proposing the option 
for selected patients. 
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